Cargando…
Cyclin D1 repressor domain mediates proliferation and survival in prostate cancer
Regulation of the androgen receptor (AR) is critical to prostate cancer (PCa) development; therefore, AR is the first line therapeutic target for disseminated tumors. Cell cycle dependent accumulation of cyclin D1 negatively modulates the transcriptional regulation of the AR through discrete, CDK4-i...
Autores principales: | Schiewer, Matthew J., Morey, Lisa M., Burd, Craig J., Liu, Yuhong, Merry, Diane E., Ho, Shuk-Mei, Knudsen, Karen E. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2852245/ https://www.ncbi.nlm.nih.gov/pubmed/19079343 http://dx.doi.org/10.1038/onc.2008.446 |
Ejemplares similares
-
AMPed up to treat prostate cancer: novel AMPK activators emerge for cancer therapy
por: Schiewer, Matthew J, et al.
Publicado: (2014) -
Cyclin D1 goes metabolic: Dual functions of cyclin D1 in regulating lipogenesis
por: Knudsen, Karen E.
Publicado: (2012) -
Consequence of the tumor-associated conversion to cyclin D1b
por: Augello, Michael A, et al.
Publicado: (2015) -
Impact of differential cyclin D1 expression and localisation in prostate cancer
por: Comstock, C E S, et al.
Publicado: (2007) -
mTOR is a selective effector of the radiation therapy response in androgen receptor-positive prostate cancer
por: Schiewer, Matthew J, et al.
Publicado: (2012)